The expansion will help broaden the company’s portfolio of SwabFlush products to reflect an increasing amount of demand in the flush syringe market.
SwabFlush is an IV catheter flush syringe that contains a disinfection cap for needleless IV connectors.
“Infection prevention is a key focus for health systems across the care continuum and it is crucial that Medline is able to provide effective solutions that enhance their initiatives,” said Dante Tisci, president of Medline’s Dynacor division, in a news release. “By enhancing and expanding our SwabFlush product line, Medline can better meet our customers’ demands for reducing the rate of infection and containing costs.”
More articles on supply chain:
Healthcare Supply Chain ranks Intermountain Healthcare #1 in nation
Corporate supply chains produce $906B in annual revenue linked to deforestation
Why this Supreme Court patent case may have expensive implications for device manufacturers
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
